Are you Dr. Doody?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin St
Suite 1801
Houston, TX 77030Phone+1 713-798-5975Fax+1 713-798-5864
Summary
- Dr. Rachelle Doody, MD is a board certified neurologist in Houston, Texas. She is currently licensed to practice medicine in Texas.
Certifications & Licensure
TX State Medical License 1983 - 2026
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's ...Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, Tanya Simuni, Kenneth Marek
Parkinsonism & Related Disorders. 2025-03-01 - 2 citationsAmyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease.Stephen Salloway, Jakub Wojtowicz, Nicola Voyle, Christopher A Lane, Gregory Klein
JAMA Neurology. 2025-01-01 - 3 citationsRacial and ethnic diversity in global neuroscience clinical trials.Loes Rutten-Jacobs, Tammy McIver, Adriana Reyes, Marta Pereira, Rachel Rosenthal
Contemporary Clinical Trials Communications. 2024-02-01
Press Mentions
CTAD 2022: Pivotal Anti-Amyloid Data and New Pathways (Updated)December 1st, 2022- Clinical Trial Set for Gantenerumab in Early-Onset Alzheimer’s DiseaseJanuary 11th, 2022
- New Alzheimer’s Prevention Trial in Young PeopleDecember 20th, 2021
- Join now to see all
